264 related articles for article (PubMed ID: 30473361)
41. Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway.
Heyninck K; Sabbe L; Chirumamilla CS; Szarc Vel Szic K; Vander Veken P; Lemmens KJA; Lahtela-Kakkonen M; Naulaerts S; Op de Beeck K; Laukens K; Van Camp G; Weseler AR; Bast A; Haenen GRMM; Haegeman G; Vanden Berghe W
Biochem Pharmacol; 2016 Jun; 109():48-61. PubMed ID: 27045103
[TBL] [Abstract][Full Text] [Related]
42. Recent Advances of Natural Polyphenols Activators for Keap1-Nrf2 Signaling Pathway.
Zhou Y; Jiang Z; Lu H; Xu Z; Tong R; Shi J; Jia G
Chem Biodivers; 2019 Nov; 16(11):e1900400. PubMed ID: 31482617
[TBL] [Abstract][Full Text] [Related]
43. Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism.
Horie Y; Suzuki T; Inoue J; Iso T; Wells G; Moore TW; Mizushima T; Dinkova-Kostova AT; Kasai T; Kamei T; Koshiba S; Yamamoto M
Commun Biol; 2021 May; 4(1):576. PubMed ID: 33990683
[TBL] [Abstract][Full Text] [Related]
44. A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.
Choi EJ; Jung BJ; Lee SH; Yoo HS; Shin EA; Ko HJ; Chang S; Kim SY; Jeon SM
Oncogene; 2017 Sep; 36(37):5285-5295. PubMed ID: 28504720
[TBL] [Abstract][Full Text] [Related]
45. Perfluoroarene-based peptide macrocycles that inhibit the Nrf2/Keap1 interaction.
Steel RJ; O'Connell MA; Searcey M
Bioorg Med Chem Lett; 2018 Sep; 28(16):2728-2731. PubMed ID: 29534931
[TBL] [Abstract][Full Text] [Related]
46. Role of human Keap1 S53 and S293 residues in modulating the binding of Keap1 to Nrf2.
Wei S; Pei Y; Wang Y; Guan H; Huang Y; Xing T; Johnson RW; Wang D
Biochimie; 2019 Mar; 158():73-81. PubMed ID: 30576774
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity.
Yasuda D; Nakajima M; Yuasa A; Obata R; Takahashi K; Ohe T; Ichimura Y; Komatsu M; Yamamoto M; Imamura R; Kojima H; Okabe T; Nagano T; Mashino T
Bioorg Med Chem Lett; 2016 Dec; 26(24):5956-5959. PubMed ID: 27839920
[TBL] [Abstract][Full Text] [Related]
48. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking.
Li M; Huang W; Jie F; Wang M; Zhong Y; Chen Q; Lu B
Food Chem Toxicol; 2019 Nov; 133():110758. PubMed ID: 31412289
[TBL] [Abstract][Full Text] [Related]
49. Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions.
Lu MC; Shao HL; Liu T; You QD; Jiang ZY
Eur J Med Chem; 2020 Dec; 207():112734. PubMed ID: 32866756
[TBL] [Abstract][Full Text] [Related]
50. Isodeoxyelephantopin induces protective autophagy in lung cancer cells via Nrf2-p62-keap1 feedback loop.
Wang Y; Zhang J; Huang ZH; Huang XH; Zheng WB; Yin XF; Li YL; Li B; He QY
Cell Death Dis; 2017 Jun; 8(6):e2876. PubMed ID: 28617433
[TBL] [Abstract][Full Text] [Related]
51. Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface.
Bhakkiyalakshmi E; Dineshkumar K; Karthik S; Sireesh D; Hopper W; Paulmurugan R; Ramkumar KM
Bioorg Med Chem; 2016 Aug; 24(16):3378-86. PubMed ID: 27312421
[TBL] [Abstract][Full Text] [Related]
52. The role of Nrf2-Keap1 signaling pathway in the antioxidant defense response induced by PAHs in the calm Ruditapes philippinarum.
Wang H; Pan L; Si L; Miao J
Fish Shellfish Immunol; 2018 Sep; 80():325-334. PubMed ID: 29920381
[TBL] [Abstract][Full Text] [Related]
53. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound.
Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A
Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152
[TBL] [Abstract][Full Text] [Related]
54. Emerging Screening Approaches in the Development of Nrf2-Keap1 Protein-Protein Interaction Inhibitors.
Leung CH; Zhang JT; Yang GJ; Liu H; Han QB; Ma DL
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509940
[TBL] [Abstract][Full Text] [Related]
55. CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1.
Lo SC; Hannink M
Mol Cell Biol; 2006 Feb; 26(4):1235-44. PubMed ID: 16449638
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
[TBL] [Abstract][Full Text] [Related]
57. New insights into the mechanism of Keap1-Nrf2 interaction based on cancer-associated mutations.
Cheng L; Wang H; Li S; Liu Z; Wang C
Life Sci; 2021 Oct; 282():119791. PubMed ID: 34229009
[TBL] [Abstract][Full Text] [Related]
58. Updated research and applications of small molecule inhibitors of Keap1-Nrf2 protein-protein interaction: a review.
Zhuang C; Miao Z; Sheng C; Zhang W
Curr Med Chem; 2014; 21(16):1861-70. PubMed ID: 24533814
[TBL] [Abstract][Full Text] [Related]
59. Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis.
Wasik U; Milkiewicz M; Kempinska-Podhorodecka A; Milkiewicz P
Sci Rep; 2017 Mar; 7():44769. PubMed ID: 28333129
[TBL] [Abstract][Full Text] [Related]
60. An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis.
Lu MC; Ji JA; Jiang YL; Chen ZY; Yuan ZW; You QD; Jiang ZY
Sci Rep; 2016 May; 6():26585. PubMed ID: 27215610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
